AbbVie
ABBV
AbbVie is a Specialty-focused, research-based biopharmaceutical company focused on developing new products and new ways to help people manage some of the most serious health conditions.
Lobbying Activity
Meeting with Ondřej Knotek (Member of the European Parliament, Shadow rapporteur)
17 Nov 2025 · Critical Medicines Act
Meeting with Michalis Hadjipantela (Member of the European Parliament)
3 Nov 2025 · Meeting about Critical Medicines Act and Biotech Act
Meeting with Ingeborg Ter Laak (Member of the European Parliament)
16 Oct 2025 · CMA and Biotech Act
Meeting with Michael Mcnamara (Member of the European Parliament)
16 Oct 2025 · Biotech Act
Meeting with Sirpa Pietikäinen (Member of the European Parliament)
16 Oct 2025 · EU initiatives in health
Meeting with Stefan Köhler (Member of the European Parliament)
16 Oct 2025 · Politischer Austausch zur UWWTD
Meeting with Jutta Paulus (Member of the European Parliament)
15 Oct 2025 · Pharmaceuticals
Meeting with Pietro Fiocchi (Member of the European Parliament)
15 Oct 2025 · Tematiche salute
Meeting with Michele Picaro (Member of the European Parliament, Rapporteur for opinion)
15 Oct 2025 · Pharmaceuticals
Meeting with Nina Carberry (Member of the European Parliament)
15 Oct 2025 · Trade Policy & Health Policy
Meeting with Jeannette Baljeu (Member of the European Parliament)
15 Oct 2025 · Critical Medicines Act
Meeting with Nicola Zingaretti (Member of the European Parliament)
15 Oct 2025 · Biotech Act
Meeting with Eero Heinäluoma (Member of the European Parliament)
15 Oct 2025 · Competitiveness, innovation, incl. Biotech Act
Meeting with Margarita De La Pisa Carrión (Member of the European Parliament)
2 Oct 2025 · Pharma Package
Meeting with Aurelijus Veryga (Member of the European Parliament)
3 Sept 2025 · Discussion on Critical Medicines Act amendments
Meeting with András Tivadar Kulja (Member of the European Parliament, Shadow rapporteur for opinion)
1 Sept 2025 · CMA
Meeting with András Tivadar Kulja (Member of the European Parliament, Shadow rapporteur for opinion)
10 Jul 2025 · Critical medicines act
Meeting with Jessica Polfjärd (Member of the European Parliament)
11 Jun 2025 · Health Policy
Meeting with Vytenis Povilas Andriukaitis (Member of the European Parliament)
5 Jun 2025 · Parkinson’s care in Europe
Meeting with Billy Kelleher (Member of the European Parliament)
25 Mar 2025 · Critical Medicines Act, Pharma legislation, trade, BioTech Act
Meeting with Sirpa Pietikäinen (Member of the European Parliament)
25 Mar 2025 · Migraine and women's health
Meeting with Michalis Hadjipantela (Member of the European Parliament)
25 Mar 2025 · Introductory Meeting
Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament)
18 Dec 2024 · Introductory Meeting
Meeting with Joanna Scheuring-Wielgus (Member of the European Parliament)
18 Dec 2024 · Women's Health and Unmet Medical Needs – Migraine, Menopause, and Other Challenges
Meeting with Niels Geuking (Member of the European Parliament)
18 Dec 2024 · Herzgesundheit
Meeting with Oliver Schenk (Member of the European Parliament)
21 Nov 2024 · Innovative Solutions to the European Health Systems
Meeting with Tomislav Sokol (Member of the European Parliament) and
17 Oct 2024 · Health policy
Meeting with Nikos Papandreou (Member of the European Parliament)
28 Feb 2024 · Review of pharmaceutical legislation
Meeting with Andreas Glück (Member of the European Parliament)
19 Feb 2024 · Pharmapaket
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and
14 Feb 2024 · Directive on Medicinal products for human use
Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament)
13 Feb 2024 · Législation pharmaceutique
Meeting with Ondřej Knotek (Member of the European Parliament)
7 Feb 2024 · Pharmaceutical package
Meeting with Cristian-Silviu Buşoi (Member of the European Parliament)
6 Feb 2024 · pharmaceutical legislation
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)
25 Jan 2024 · Directive on Medicinal products for human use
Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and
23 Jan 2024 · Pharmaceutical Package (Regulation)
Meeting with Peter Liese (Member of the European Parliament) and
22 Jan 2024 · Austausch
Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and A. Menarini Industrie Farmaceutiche Riunite s.r.l.
18 Dec 2023 · Revision of Pharmaceutical Package (staff level)
Meeting with Pascal Arimont (Member of the European Parliament) and RPP Group
13 Dec 2023 · Revision of Pharmaceutical Legislation
Meeting with Frédérique Ries (Member of the European Parliament, Shadow rapporteur)
12 Dec 2023 · Revision of the Pharmaceutical Legislation
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Platform for Better Oral Health in Europe
7 Dec 2023 · Directive on Medicinal products for human use
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)
31 Oct 2023 · Directive on Medicinal products for human use
Meeting with Erik Poulsen (Member of the European Parliament) and
30 Oct 2023 · Pharmaceuticals legislation
Meeting with Andrey Slabakov (Member of the European Parliament, Shadow rapporteur)
25 Oct 2023 · Reform of the EU pharmaceutical legislation
Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and
25 Oct 2023 · Pharmaceutical legislation
Meeting with Mairead McGuinness (Commissioner) and
21 Sept 2023 · Discussions covered AbbVie’s presence in Europe including 5 major sites in Ireland; the sector’s demand for skills and training; the pharmaceutical strategy for Europe and access to medicine in Ireland.
Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and
7 Sept 2023 · Revision of the Pharmaceutical Legislation (staff level)
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and
18 Jul 2023 · Directive on Medicinal products for human use
Meeting with Pascal Arimont (Member of the European Parliament)
12 Jul 2023 · Reform of the EU pharmaceutical legislation
Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and Bundesverband der Pharmazeutischen Industrie e.V.
28 Jun 2023 · Revision of Pharmaceutical Legislation (staff level)
Meeting with Deirdre Clune (Member of the European Parliament)
23 Jun 2023 · Launch of STEM project
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and European Federation of Pharmaceutical Industries and Associations
13 Jun 2023 · Directive on Medicinal products for human use
Meeting with Elina Melngaile (Cabinet of Executive Vice-President Valdis Dombrovskis), Zaneta Vegnere (Cabinet of Executive Vice-President Valdis Dombrovskis) and
5 Jun 2023 · Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement
Meeting with Nicola Beer (Member of the European Parliament) and
27 May 2023 · Exhange of views
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)
23 May 2023 · Medicinal products for human use
Meeting with Valérie Hayer (Member of the European Parliament)
25 Apr 2023 · Industrial sector and strategic autonomy
Meeting with Vlad-Marius Botoş (Member of the European Parliament)
23 Feb 2023 · A pharmaceutical strategy for Europe
Meeting with Pascal Arimont (Member of the European Parliament) and RPP Group
16 Feb 2023 · Pharmaceutical Innovation and European Strategic Autonomy
Meeting with Klemen Grošelj (Member of the European Parliament)
15 Feb 2023 · Europe´s open strategic autonomy
Meeting with Lara Wolters (Member of the European Parliament, Rapporteur)
8 Feb 2023 · Meeting due diligence directive
Meeting with Frédérique Ries (Member of the European Parliament)
11 Jan 2023 · Maintenir l'innovation pharmaceutique en Europe et l'accès des patients aux médicaments
Meeting with Alin Mituța (Member of the European Parliament, Shadow rapporteur)
22 Sept 2022 · School Scheme
Meeting with Antonius Manders (Member of the European Parliament)
13 Sept 2022 · Pharmaceutical strategy
Meeting with Jens Gieseke (Member of the European Parliament)
7 Sept 2022 · Austausch zur Europapolitik
Meeting with Andreas Glück (Member of the European Parliament)
7 Sept 2022 · Pharma Strategy
Meeting with Stéphane Séjourné (Member of the European Parliament)
1 Sept 2022 · Propriété intellectuelle (équipe)
Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)
21 Jun 2022 · rare cancers
Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)
30 May 2022 · Medicines
Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC
27 Apr 2021
Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products
6 Jan 2021
Meeting with Alina-Stefania Ujupan (Cabinet of Executive Vice-President Margrethe Vestager)
24 Nov 2020 · Pharmaceutical innovation and research in Europe
Meeting with Christine Schneider (Member of the European Parliament)
25 May 2020 · Gesundheitspolitische Themen
Response to Commission Communication on Europe’s Beating Cancer Action Plan
3 Mar 2020
Meeting with Tom Tynan (Cabinet of Commissioner Phil Hogan)
24 May 2018 · Business discussion
Meeting with Leila Fernandez-Stembridge (Cabinet of Commissioner Pierre Moscovici)
27 Mar 2018 · IP regime generic manufacturers in the pharmaceutical industry
Meeting with Nele Eichhorn (Cabinet of Vice-President Cecilia Malmström) and Portland PR Europe Limited
26 Mar 2018 · SPC waiver